(Q46005294)

18 December 2017

title

Immune cell membrane fatty acids and inflammatory marker, C-reactive protein, in patients with multiple sclerosis. (English)

1 reference

18 December 2017

0 references

0 references

Gloudina Hon

1

1 reference

18 December 2017

Mogamat Hassan

2

1 reference

18 December 2017

Susan Janse van Rensburg

3

1 reference

18 December 2017

Stefan Abel

4

1 reference

18 December 2017

De Wet Marais

5

1 reference

18 December 2017

Paul van Jaarsveld

6

1 reference

18 December 2017

Cornelius Smuts

7

1 reference

18 December 2017

Franclo Henning

8

1 reference

18 December 2017

Rajiv Erasmus

9

1 reference

18 December 2017

Tandi Matsha

10

1 reference

18 December 2017

publication date

19 May 2009

1 reference

18 December 2017

British Journal of Nutrition

published in

1 reference

18 December 2017

volume

102

1 reference

18 December 2017

issue

9

1 reference

18 December 2017

page(s)

1334-1340

1 reference

18 December 2017

Ubiquitous pathogens: links between infection and autoimmunity in MS?

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS0007114509382185

Soluble E-selectin in multiple sclerosis: raised concentrations in patients with primary progressive disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114509382185

Factors modifying the migration of lymphocytes across the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114509382185

Relationships between serum fatty acid composition and multiple markers of inflammation and endothelial function in an elderly population

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114509382185

Polyunsaturated fatty acids in the pathogenesis and treatment of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114509382185

Prostaglandin E inhibits the production of human interleukin 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114509382185

Modulatory effects of dietary lipids on immune system functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114509382185

Omega-3 fatty acids in inflammation and autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114509382185

Differential effects of prostaglandin derived from omega-6 and omega-3 polyunsaturated fatty acids on COX-2 expression and IL-6 secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114509382185

Atorvastatin decreases high-sensitivity C-reactive protein in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114509382185

Serum inflammatory markers and clinical/MRI markers of disease progression in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114509382185

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114509382185

Relationship between plasma and lymphocyte linoleate in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114509382185

Eicosanoids in inflammation: biosynthesis, pharmacology, and therapeutic frontiers

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114509382185

Immunomodulation by omega-3 fatty acids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114509382185

Linoleic acid levels in white blood cells, platelets, and serum of multiple sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114509382185

7 January 2021

Alteration of polyunsaturated fatty acid status and metabolism in health and disease.

1 reference

https://api.crossref.org/works/10.1017%2FS0007114509382185

7 January 2021

Biochemistry of essential fatty acids

1 reference

https://api.crossref.org/works/10.1017%2FS0007114509382185

7 January 2021

Pathology of multiple sclerosis: progression of the lesion

1 reference

https://api.crossref.org/works/10.1017%2FS0007114509382185

7 January 2021

Hexagonal phases in phospholipids with saturated chains: phosphatidylethanolamines and phosphatidic acids

1 reference

https://api.crossref.org/works/10.1017%2FS0007114509382185

7 January 2021

Sialic acid and fatty acid concentrations in lymphocytes, red blood cells and plasma from patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1017%2FS0007114509382185

7 January 2021

Dietary intake of fatty acids and serum C-reactive protein in Japanese

1 reference

https://api.crossref.org/works/10.1017%2FS0007114509382185

7 January 2021

Serum fatty acid composition and indices of stearoyl-CoA desaturase activity are associated with systemic inflammation: longitudinal analyses in middle-aged men.

1 reference

https://api.crossref.org/works/10.1017%2FS0007114509382185

7 January 2021

Plasma phospholipid fatty acids and CHD in older men: Whitehall study of London civil servants

1 reference

https://api.crossref.org/works/10.1017%2FS0007114509382185

7 January 2021

The fatty acids of myelin phospholipids

1 reference

https://api.crossref.org/works/10.1017%2FS0007114509382185

7 January 2021

Inflammatory demyelination is not central to the pathogenesis of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1017%2FS0007114509382185

7 January 2021

10.1017/S0007114509382185

Identifiers

DOI

1 reference

18 December 2017

1 reference

18 December 2017